HOE-140, an antagonist of B2 receptor, protects against memory deficits and brain damage induced by moderate lateral fluid percussion injury in mice

Psychopharmacology

Volumn 231, Issue 9, 2014, Pages 1935-1948

  Ferreira, Ana Paula Oliveira ^a   Rodrigues, Fernanda Silva ^a   Della Pace, Iuri Domingues ^a   Mota, Bibiana Castagna ^a   Oliveira, Sara Marchesan ^a   De Campos Velho Gewehr, Camila ^a   Bobinski, Franciane ^b   De Oliveira, Clarissa Vasconcelos ^a   Brum, Juliana Sperotto ^a   Oliveira, Mauro Schneider ^a   Furian, Ana Flavia ^a   De Barros, Claudio Severo Lombardo ^a   Dos Santos, Adair Roberto Soares ^b   Ferreira, Juliano ^a   Fighera, Michele Rechia ^a   Royes, Luiz Fernando Freire ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Bradykinin; Inflammation; Object recognition task; Oxidative stress; Traumatic brain injury

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; ICATIBANT; INTERLEUKIN 1BETA; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; BRADYKININ; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ, LEU(8)-DES-ARG(9)-; NEUROPROTECTIVE AGENT;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN CORTEX; BRAIN DAMAGE; BRAIN EDEMA; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ELEVATED PLUS MAZE TEST; ENCEPHALITIS; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN FUNCTION; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; BRAIN INJURIES; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; MAZE TEST; MEMORY DISORDERS; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; PHYSIOLOGY; RECOGNITION; TIME;

ANIMALS; BRADYKININ; BRADYKININ B1 RECEPTOR ANTAGONISTS; BRADYKININ B2 RECEPTOR ANTAGONISTS; BRAIN; BRAIN EDEMA; BRAIN INJURIES; DISEASE MODELS, ANIMAL; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MOTOR ACTIVITY; NADPH OXIDASE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RECOGNITION (PSYCHOLOGY); TIME FACTORS;

EID: 84899648820     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3336-x     Document Type: Article

References (71)

1. Aiguo W, Zhe Y, Gomez-Pinilla F (2010) Vitamin E protects against oxidative damage and learning disability after mild traumatic brain injury in rats. Neurorehabil Neural Repair 24:290-298. doi: 10.1177/1545968309348318
2. Albert-Weissenberger C, Stetter C, Meuth SG, Gobel K, Bader M, Siren AL, Kleinschnitz C (2012) Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation. J Cereb Blood Flow Metab 32:1747-1756. doi: 10.1038/jcbfm.2012.62
3. Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Sener M, Kocak A, Yologlu S (2007) Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem 294:137-144. doi: 10.1007/s11010-006-9253-0
4. Austinat M, Braeuninger S, Pesquero JB, Brede M, Bader M, Stoll G, Renne T, Kleinschnitz C (2009) Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke 40:285-293. doi: 10.1161/STROKEAHA.108.526673
5. Ayer R, Jadhav V, Sugawara T, Zhang JH (2011) The neuroprotective effects of cyclooxygenase-2 inhibition in a mouse model of aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 111:145-149. doi: 10.1007/978-3-7091-0693-8-24
6. Baratz R, Tweedie D, Rubovitch V, Luo W, Yoon JS, Hoffer BJ, Greig NH, Pick CG (2011) Tumor necrosis factor-alpha synthesis inhibitor, 3,6′-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice. J Neurochem 118:1032-1042. doi: 10.1111/j.1471-4159.2011.07377.x
7. Bay E, Covassin T (2012) Chronic stress, somatic and depressive symptoms following mild to moderate traumatic brain injury. Arch Psychiatr Nurs 26:477-486. doi: 10.1016/j.apnu.2012.06.002
8. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
9. Carbonell WS, Maris DO, McCall T, Grady MS (1998) Adaptation of the fluid percussion injury model to the mouse. J Neurotrauma 15:217-229
10. Chao J, Woodley C, Chao L, Margolius HS (1983) Identification of tissue kallikrein in brain and in the cell-free translation product encoded by brain mRNA. J Biol Chem 258:15173-15178
11. Clausen F, Lundqvist H, Ekmark S, Lewen A, Ebendal T, Hillered L (2004) Oxygen free radical-dependent activation of extracellular signal-regulated kinase mediates apoptosis-like cell death after traumatic brain injury. J Neurotrauma 21:1168-1182. doi: 10.1089/neu.2004.21.1168
12. Clausen F, Hanell A, Bjork M, Hillered L, Mir AK, Gram H, Marklund N (2009) Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci 30:385-396. doi: 10.1111/j.1460-9568.2009.06820.x
13. Correa FM, Innis RB, Uhl GR, Snyder SH (1979) Bradykinin-like immunoreactive neuronal systems localized histochemically in rat brain. Proc Natl Acad Sci U S A 76:1489-1493
14. Donkin JJ, Vink R (2010) Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments. Curr Opin Neurol 23:293-299. doi: 10.1097/WCO.0b013e328337f451
15. Gahm C, Holmin S, Wiklund PN, Brundin L, Mathiesen T (2006) Neuroprotection by selective inhibition of inducible nitric oxide synthase after experimental brain contusion. J Neurotrauma 23:1343-1354. doi: 10.1089/neu.2006.23.1343
16. Gilgun-Sherki Y, Rosenbaum Z, Melamed E, Offen D (2002) Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 54:271-284
17. Gorlach C, Hortobagyi T, Hortobagyi S, Benyo Z, Relton J, Whalley ET, Wahl M (2001) Bradykinin B2, but not B1, receptor antagonism has a neuroprotective effect after brain injury. J Neurotrauma 18:833-838. doi: 10.1089/089771501316919193
18. Groger M, Lebesgue D, Pruneau D, Relton J, Kim SW, Nussberger J, Plesnila N (2005) Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25:978-989. doi: 10.1038/sj.jcbfm. 9600096
19. Hall JM (1992) Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther 56:131-190
20. Hellal F, Pruneau D, Palmier B, Faye P, Croci N, Plotkine M, Marchand-Verrecchia C (2003) Detrimental role of bradykinin B2 receptor in a murine model of diffuse brain injury. J Neurotrauma 20:841-851. doi: 10.1089/089771503322385773
21. Hsieh HL, Wang HH, Wu CY, Yang CM (2010) Reactive oxygen species-dependent c-Fos/activator protein 1 induction upregulates heme oxygenase-1 expression by bradykinin in brain astrocytes. Antioxid Redox Signal 13:1829-1844. doi: 10.1089/ars.2009.2957
22. Ivashkova Y, Svetnitsky A, Mayzler O, Pruneau D, Benifla M, Fuxman Y, Cohen A, Artru AA, Shapira Y (2006) Bradykinin B2 receptor antagonism with LF 18-1505T reduces brain edema and improves neurological outcome after closed head trauma in rats. J Trauma 61:879-885. doi: 10.1097/01.ta.0000234722.98537.01
23. +, K(+)-ATPase activity by oxygen free radicals. Neuroreport 7:333-337
24. Kaplanski J, Pruneau D, Asa I, Artru AA, Azez A, Ivashkova Y, Rudich Z, Shapira Y (2002) LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats. J Neurotrauma 19:953-964. doi: 10.1089/089771502320317104
25. Kaplanski J, Asa I, Artru AA, Azez A, Ivashkova Y, Rudich Z, Pruneau D, Shapira Y (2003) LF 16-0687 Ms, a new bradykinin B2 receptor antagonist, decreases ex vivo brain tissue prostaglandin E2 synthesis after closed head trauma in rats. Resuscitation 56:207-213
26. Klasner B, Lumenta DB, Pruneau D, Zausinger S, Plesnila N (2006) Therapeutic window of bradykinin B2 receptor inhibition after focal cerebral ischemia in rats. Neurochem Int 49:442-447. doi: 10.1016/j.neuint.2006.02.010
27. Komada M, Takao K, Miyakawa T (2008) Elevated plus maze for mice. J Vis Exp. doi: 10.3791/1088
28. Lee YJ, Zachrisson O, Tonge DA, McNaughton PA (2002) Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons. Mol Cell Neurosci 19:186-200. doi: 10.1006/mcne.2001.1073
29. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478
30. +-ATPase activity impairment after experimental traumatic brain injury: relationship to spatial learning deficits and oxidative stress. Behav Brain Res 193:306-310. doi: 10.1016/j.bbr.2008.05.013
31. +-ATPase activity inhibition after traumatic brain injury. Brain Res 1279:147-155. doi: 10.1016/j.brainres.2009.04. 052
32. Lin CC, Hsieh HL, Shih RH, Chi PL, Cheng SE, Chen JC, Yang CM (2012) NADPH oxidase 2-derived reactive oxygen species signal contributes to bradykinin-induced matrix metalloproteinase-9 expression and cell migration in brain astrocytes. Cell Commun Signal 10:35. doi: 10.1186/1478-811X-10-35
33. Liu HT, Akita T, Shimizu T, Sabirov RZ, Okada Y (2009) Bradykinin-induced astrocyte-neuron signalling: glutamate release is mediated by ROS-activated volume-sensitive outwardly rectifying anion channels. J Physiol 587:2197-2209. doi: 10.1113/jphysiol.2008.165084
34. Lu J, Moochhala S, Shirhan M, Ng KC, Teo AL, Tan MH, Moore XL, Wong MC, Ling EA (2003) Neuroprotection by aminoguanidine after lateral fluid-percussive brain injury in rats: a combined magnetic resonance imaging, histopathologic and functional study. Neuropharmacology 44:253-263
35. Marceau F, Regoli D (2004) Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3:845-852. doi: 10.1038/nrd1522
36. Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62-71. doi: 10.1006/niox.2000.0319
37. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A (2005) The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 99:6-38
38. Noda M, Kariura Y, Amano T, Manago Y, Nishikawa K, Aoki S, Wada K (2003) Expression and function of bradykinin receptors in microglia. Life Sci 72:1573-1581
39. Noda M, Kariura Y, Pannasch U, Nishikawa K, Wang L, Seike T, Ifuku M, Kosai Y, Wang B, Nolte C, Aoki S, Kettenmann H, Wada K (2007) Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem 101:397-410. doi: 10.1111/j.1471-4159.2006.04339.x
40. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
41. Plesnila N, Schulz J, Stoffel M, Eriskat J, Pruneau D, Baethmann A (2001) Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats. J Neurotrauma 18:1049-1058. doi: 10.1089/08977150152693746
42. Potts MB, Koh SE, Whetstone WD, Walker BA, Yoneyama T, Claus CP, Manvelyan HM, Noble-Haeusslein LJ (2006) Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets. NeuroRx 3:143-153. doi: 10.1016/j.nurx.2006.01.006
43. Pun PB, Lu J, Moochhala S (2009) Involvement of ROS in BBB dysfunction. Free Radic Res 43:348-364. doi: 10.1080/10715760902751902
44. Raghupathi R, Fernandez SC, Murai H, Trusko SP, Scott RW, Nishioka WK, McIntosh TK (1998) BCL-2 overexpression attenuates cortical cell loss after traumatic brain injury in transgenic mice. J Cereb Blood Flow Metab 18:1259-1269. doi: 10.1097/00004647-199811000-00013
45. Raidoo DM, Bhoola KD (1998) Pathophysiology of the kallikrein-kinin system in mammalian nervous tissue. Pharmacol Ther 79:105-127
46. Raslan F, Schwarz T, Meuth SG, Austinat M, Bader M, Renne T, Roosen K, Stoll G, Siren AL, Kleinschnitz C (2010) Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J Cereb Blood Flow Metab 30:1477-1486. doi: 10.1038/jcbfm.2010.28
47. Schneider Oliveira M, Flavia Furian A, Freire Royes LF, Rechia Fighera M, de Carvalho Myskiw J, Gindri Fiorenza N, Mello CF (2004) Ascorbate modulates pentylenetetrazol-induced convulsions biphasically. Neuroscience 128:721-728. doi: 10.1016/j.neuroscience.2004.07.012
48. +-ATPase activity and free radical generation in the susceptibility to pentylenetetrazol-induced seizures after experimental traumatic brain injury. J Neurol Sci 308:35-40. doi: 10.1016/j.jns.2011.06.030
49. Silva LF, Hoffmann MS, Gerbatin R, Fiorin F, Dobrachinski F, Mota BC, Wouters AT, Soares FA, Pavarini SP, Fighera MR, Royes LF (2013) Treadmill exercise protects against pentylenetetrazol-induced seizures and oxidative stress after traumatic brain injury. J Neurotrauma. doi: 10.1089/neu.2012.2577
50. Singleton RH, Yan HQ, Fellows-Mayle W, Dixon CE (2010) Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury. J Neurotrauma 27:1091-1099. doi: 10.1089/neu.2010.1291
51. Sosin DM, Sniezek JE, Waxweiler RJ (1995) Trends in death associated with traumatic brain injury, 1979 through 1992. Success and failure. JAMA 273:1778-1780
52. +-ATPase activity, seizures, and oxidative stress. Epilepsia 50:811-823. doi: 10.1111/j.1528-1167.2008.01908.x
53. Stokely ME, Orr EL (2008) Acute effects of calvarial damage on dural mast cells, pial vascular permeability, and cerebral cortical histamine levels in rats and mice. J Neurotrauma 25:52-61. doi: 10.1089/neu.2007.0397
54. Stover JF, Dohse NK, Unterberg AW (2000) Significant reduction in brain swelling by administration of nonpeptide kinin B2 receptor antagonist LF 16-0687Ms after controlled cortical impact injury in rats. J Neurosurg 92:853-859. doi: 10.3171/jns.2000.92.5.0853
55. Su J, Cui M, Tang Y, Zhou H, Liu L, Dong Q (2009) Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition. Biochem Biophys Res Commun 388:205-211. doi: 10.1016/j.bbrc.2009.07.135
56. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J Biol Chem 270:30334-30338
57. Theodoros DG, Shrapnel N, Murdoch BE (1998) Motor speech impairment following traumatic brain injury in childhood: a physiological and perceptual analysis of one case. Pediatr Rehabil 2:107-122
58. Trabold R, Eros C, Zweckberger K, Relton J, Beck H, Nussberger J, Muller-Esterl W, Bader M, Whalley E, Plesnila N (2010) The role of bradykinin B(1) and B(2) receptors for secondary brain damage after traumatic brain injury in mice. J Cereb Blood Flow Metab 30:130-139. doi: 10.1038/jcbfm.2009.196
59. Unterberg AW, Stover J, Kress B, Kiening KL (2004) Edema and brain trauma. Neuroscience 129:1021-1029. doi: 10.1016/j.neuroscience.2004.06.046
60. Wada K, Chatzipanteli K, Busto R, Dietrich WD (1998a) Role of nitric oxide in traumatic brain injury in the rat. J Neurosurg 89:807-818. doi: 10.3171/jns.1998.89.5.0807
61. Wada K, Chatzipanteli K, Kraydieh S, Busto R, Dietrich WD (1998b) Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats. Neurosurgery 43:1427-1436
62. Wada K, Chatzipanteli K, Busto R, Dietrich WD (1999) Effects of L-NAME and 7-NI on NOS catalytic activity and behavioral outcome after traumatic brain injury in the rat. J Neurotrauma 16:203-212
63. Walker K, Perkins M, Dray A (1995) Kinins and kinin receptors in the nervous system. Neurochem Int 26:1-16; discussion 17-26
64. Werner C, Engelhard K (2007) Pathophysiology of traumatic brain injury. Br J Anaesth 99:4-9. doi: 10.1093/bja/aem131
65. Writer BW, Schillerstrom JE (2009) Psychopharmacological treatment for cognitive impairment in survivors of traumatic brain injury: a critical review. J Neuropsychiatry Clin Neurosci 21:362-370. doi: 10.1176/appi.neuropsych.21.4. 362
66. Yan LJ, Traber MG, Packer L (1995) Spectrophotometric method for determination of carbonyls in oxidatively modified apolipoprotein B of human low-density lipoproteins. Anal Biochem 228:349-351. doi: 10.1006/abio.1995.1362
67. Yang CM, Hsieh HL, Lin CC, Shih RH, Chi PL, Cheng SE, Hsiao LD (2013) Multiple factors from bradykinin-challenged astrocytes contribute to the neuronal apoptosis: involvement of astroglial ROS, MMP-9, and HO-1/CO system. Mol Neurobiol 47:1020-1033. doi: 10.1007/s12035-013-8402-1
68. Zhan H, Tada T, Nakazato F, Tanaka Y, Hongo K (2004) Spatial learning transiently disturbed by intraventricular administration of ouabain. Neurol Res 26:35-40. doi: 10.1179/016164104773026507
69. Ziebell JM, Bye N, Semple BD, Kossmann T, Morganti-Kossmann MC (2011) Attenuated neurological deficit, cell death and lesion volume in Fas-mutant mice is associated with altered neuroinflammation following traumatic brain injury. Brain Res 1414:94-105. doi: 10.1016/j.brainres.2011.07.056
70. Zink BJ (2001) Traumatic brain injury outcome: concepts for emergency care. Ann Emerg Med 37:318-332. doi: 10.1067/mem.2001.113505
71. Zweckberger K, Eros C, Zimmermann R, Kim SW, Engel D, Plesnila N (2006) Effect of early and delayed decompressive craniectomy on secondary brain damage after controlled cortical impact in mice. J Neurotrauma 23:1083-1093. doi: 10.1089/neu.2006.23.1083